The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global chemoinformatics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 13% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.
Chemoinformatics is a new field of information technology (IT) that focuses on the collection, storage, analysis, and manipulation of chemical data. The chemical data includes small molecule formulas, structures, properties, spectra, and biological and industrial activities. Chemoinformatics helps define archival data protocols and represent three-dimensional (3D) molecular structures, which further enables searching and comparing of compounds with specific features. As a result, it is widely used in the pharmaceutical industry to discover and develop novel biotechnological processes and products.
At present, the outbreak of coronavirus disease (COVID-19) represents one of the major factors positively influencing the utilization of chemoinformatics in anti-viral research or discovery of therapeutics against the disease. Apart from this, the surging cases of chronic diseases and the consequent need for novel drugs are also influencing the market growth. The increasing investments in research and development (R&D) projects are also catalyzing the demand for chemoinformatics to validate potential drug candidates and the effective management of data generated during molecular and atomic reactions. Moreover, the increasing awareness about personalized medicine is driving the market growth. Due to the massive amount of data generated while synthesizing new drugs, the leading market players are integrating advanced information storage and retrieval technologies in chemoinformatics. This helps researchers in efficiently storing information about the physical properties, 3D molecular and crystal structures, spectroscopic signatures, chemical reaction pathways, molecular functional groups and docking sites, and other parameters. These innovations are anticipated to propel the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global chemoinformatics market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region and application.
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioSolveIT GmbH, BIOVIA (Dassault Systèmes), ChemAxon, Inc., Eurofins CEREP SA (Eurofins Panlabs Inc.), Jubilant Biosys Inc., Molecular Discovery Ltd., OpenEye Scientific Software Inc. and Schrödinger Inc.
|Base Year of the Analysis||2020|
|Segment Coverage||Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioSolveIT GmbH, BIOVIA (Dassault Systèmes), ChemAxon, Inc., Eurofins CEREP SA (Eurofins Panlabs Inc.), Jubilant Biosys Inc., Molecular Discovery Ltd., OpenEye Scientific Software Inc. and Schrödinger Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at